Both in Pharmaceuticals
Arvinas vs Crescent Biopharma
Over the past year ARVN returned −19.1% and CBIO returned +9.1%; their daily moves had a correlation of 0.29.
ARVN −19.1% CBIO +9.1%Growth of $1, one year, split-adjusted
| Metric | ARVN | CBIO |
|---|---|---|
| Price | $7.86 | $13.48 |
| Market cap | $513.9M | $500.7M |
| Today | −0.51% | −4.19% |
| 1 month | +5.8% | −5.5% |
| 6 months | −25.2% | −25.4% |
| Year to date | −33.7% | +13.7% |
| 1 year | −18.0% | +7.8% |
| Revenue growth (YoY) | +1014.7% | — |
| Gross margin | 96.4% | — |
| Net margin | 67.8% | — |
| P/E (TTM) | 55.3× | — |
| Price / sales | 1.6× | 42.1× |
| Net cash | $567.6M | $171.6M |
| Dividend yield | — | — |
| Volatility (60d) | 46.6% | 68.9% |
| Short % of float | 10.2% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).